XML 108 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Capital Management (Tables)
 12 Months Ended
Dec. 31, 2019
Corporate Information And Statement Of IFRS Compliance [Abstract]  
Schedule of Total Capital
For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as was prescribed by OSFI, to the total capital figure presented in the table below:
As at December 31,
2019
 
2018
 
Subordinated debt
 
$
3,538

 
$
3,039

Innovative capital instruments(1)
 
200

 
699

Equity:
 
 
 
 
Preferred shareholders’ equity
 
2,257

 
2,257

Common shareholders’ equity
 
21,141

 
21,449

Participating policyholders’ equity
 
1,091

 
864

Non-controlling interests’ equity
 
19

 
—

Total capital
 
$
28,246

 
$
28,308


(1) Innovative capital instruments are SLEECS issued by the SL Capital Trusts (Note 13). The SL Capital Trusts are not consolidated by us.